VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/13/13 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) is pleased to announce that it has been recognized as a TSX Venture 50® company in 2013. The 2013 TSX Venture 50® includes the top 10 companies in 5 major industry sectors that have been identified as leaders in providing shareholder value on Canada's junior stock exchange.
"We couldn't be more pleased to be included in the 2013 TSX Venture 50® as a member of the Technology and Life Sciences sector," said Calyx President and CEO Hugh Notman. "This honour continues to build momentum for Calyx, as we continue our efforts to promote Resonance carinata, a non-food oilseed crop for use in biofuels, through our majority-owned subsidiary Agrisoma Biosciences Inc. It's not only a recognition for our company-it's also a nod to our shareholders for their vision."
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors - mining, oil & gas, technology & life sciences, diversified industries and clean technology - based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2012.
TSX Venture 50® is a trade-mark of TSX Inc. and is used under license.
Calyx Bio-Ventures Inc. trades on the TSX Venture Exchange under the symbol "CYX" and owns a majority position in Agrisoma Biosciences Inc. Agrisoma is an agricultural biotechnology company that uses a proprietary Engineered Trait Loci (ETL) technology licensed from Calyx to commercialize a suite of industry-leading oil quality and crop improvement traits for use in energy feedstock crops. Agrisoma is currently commercializing Resonance carinata, a non-food oilseed crop that is well suited for cultivation on semi-arid lands. For further information about Calyx, its technology, collaborations and partnerships, please visit www.calyxbio.com. For more information about Agrisoma, visit www.agrisoma.com.
This press release shall not constitute an offer to sell, nor the solicitation of an offer to buy, any securities in the United States, nor shall there be any sale of securities mentioned in this press release in any state in the United States in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
Calyx Bio-Ventures Inc.
Most Popular Stories
- Koch Brothers Step up Anti-Obamacare Campaign
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- Quiznos Files for Chapter 11
- FDIC Sues Big Banks Over Rate Manipulation
- U.S. to Relinquish Gov't Control Over Internet
- Keurig Adds Peet's coffee, Alters Starbucks deal
- Vybz Kartel Convicted of Murder
- SoCalGas Reaches Record Spend on Diversity Suppliers
- U.S. Consumer Sentiment Falls in Early March